Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation
Clinical trial NCT02458235 · COMPLETED
Trial details
- NCT number
- NCT02458235
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-02
- Primary completion
- 2019-03-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.